Navigation Links
AdvaMed Available for Comment on Medical Device Safety Act
Date:3/5/2009

WASHINGTON, March 5 /PRNewswire-USNewswire/ -- Stephen J. Ubl, president and CEO of the Advanced Medical Technology Association (AdvaMed), is available today to discuss the Medical Device Safety Act to be introduced today in Congress.

If the Act were to become law, it would:

  • Chill innovation and limit patient access to cutting-edge, life-enhancing therapies; and
  • Dramatically alter the regulatory environment for certain medical devices, by creating new avenues for litigation.

To arrange an interview with Steve Ubl, please contact: Wanda Moebius at 202-434-7240.

AdvaMed member companies produce the medical devices, diagnostic products and health information systems that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. Our members produce nearly 90 percent of the health care technology purchased annually in the United States and more than 50 percent purchased annually around the world. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit www.advamed.org.

    CONTACT: Wanda Moebius
    wmoebius@advamed.org
    202-434-7240


'/>"/>
SOURCE Advanced Medical Technology Association
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. AdvaMed Response to the Medical Device Safety Act
2. Gerson Lehrman Group Partners With AdvaMed for Survey on Medical Device Industry
3. AdvaMed 2008 Sponsor Participation Increases by 52%
4. AdvaMed 2008 Opens Showcasing Latest Medical Technologies with Innovation Alley Exhibit and Next Generation Company Presentations
5. Canadian, German, Israeli, New Zealand, U.K and U.S. Companies Selected to Make Company Presentations at AdvaMed 2008
6. AdvaMed 2008 Supporting Partner Organizations Up 30% Over Last Year
7. AdvaMed Supports Key Changes to Disclosure Legislation
8. AdvaMed Supports Increased Funding for FDA
9. AdvaMed Convenes Panel to Address Health Disparities
10. AdvaMed 2007 Exceeds Attendance Expectations With More Than 1,100 Participants from 35 States and 25 Countries
11. Innovation and Medical Advances to be Highlighted on Final Day of Inaugural AdvaMed 2007 Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, ... remain in the eye of the beholder, according to experts who offered insights and ... Journal of Managed Care. For the full issue, click here . , For ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women ... diagnosed with endometriosis. These women need a treatment plan to not only alleviate ... that can help for preservation of fertility and ultimately achieving a pregnancy. The ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: